v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities:    
Net loss $ (11,981) $ (18,895)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,646 7,469
Amortization of debt discount 320 601
Non-cash operating lease expense 1,911 1,360
Unrealized (gain) loss on investments in equity securities (659) 678
Realized loss on available-for-sale investments 851 (2,416)
Stock-based compensation expense 3,700 5,456
Loss on disposal of property and equipment 4 131
Change in credit losses (31) 99
Excess and obsolete inventory 145  
Change in contingent consideration (5,183) 293
Changes in operating assets and liabilities:    
Accounts receivable 778 437
Inventories (2,305) 1,113
Prepaid expenses and other current assets 394 (1,174)
Deposits (167) (9)
Operating lease liabilities (1,288) (1,302)
Accounts payable and other accrued expenses (783) 264
Accrued compensation and related expenses 1,633 2,719
Deferred revenue 699 462
Net deferred tax liability (26) (551)
Net cash used in operating activities (4,342) (3,265)
Cash Flows From Investing Activities:    
Purchases of property and equipment (3,168) (4,006)
Software development costs (555) (443)
Purchases of short-term investments   (14,038)
Sales/maturities of short-term investments 10,000 25,250
Patent and trademark costs (355) (318)
Net cash provided by investing activities 5,922 6,445
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 3 618
Repayment of notes payable (37) (36)
Repayment of finance lease liabilities (155) (70)
Net cash provided by (used in) financing activities (189) 512
Effect of exchange rates on cash and cash equivalents 681 (375)
Net change in cash and cash equivalents 2,072 3,317
Cash and cash equivalents - beginning of period 45,289 46,346
Cash and cash equivalents - end of period 47,361 49,663
Reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:    
Cash and cash equivalents from continuing operations - beginning of period 34,137 35,192
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - beginning of period 11,152 11,154
Total cash and cash equivalents - beginning of period 45,289 46,346
Cash and cash equivalents from continuing operations - end of period 36,102 39,294
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - end of period 11,259 10,369
Total cash and cash equivalents - end of period 47,361 49,663
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 36 38
Cash paid for income taxes 408 417
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 2,286  
Net unrealized gain on available-for-sale debt securities 808 261
Reclassification of realized gain (loss) on available-for-sale debt securities to earnings 854 (2,314)
Paid-in-kind preferred stock dividend, including beneficial conversion feature 2,000 2,000
Fixed assets included in accounts payable and accrued liabilities 189 542
Contingent consideration reclassed to accounts payable and accrued liabilities 833  
Purchase of equipment through finance lease obligation $ 39 $ 63

Source

10-Q PDF XBRL Zip